| The influence of hepatitis C virus genetic region on phylogenetic clustering analysis FMJ Lamoury, B Jacka, S Bartlett, RA Bull, A Wong, J Amin, J Schinkel, ... PloS one 10 (7), e0131437, 2015 | 32 | 2015 |
| Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A systematic review SR Bartlett, J Grebely, AA Eltahla, JD Reeves, AYM Howe, V Miller, ... Hepatology communications 1 (5), 379-390, 2017 | 28 | 2017 |
| Demonstration of near-elimination of hepatitis C virus among a prison population: the Lotus Glen Correctional Centre hepatitis C treatment project SR Bartlett, P Fox, H Cabatingan, A Jaros, C Gorton, R Lewis, E Priscott, ... Clinical Infectious Diseases 67 (3), 460-463, 2018 | 18 | 2018 |
| A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies SR Bartlett, JO Wertheim, RA Bull, GV Matthews, FMJ Lamoury, ... Journal of viral hepatitis 24 (5), 404-411, 2017 | 12 | 2017 |
| HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection SR Bartlett, B Jacka, RA Bull, F Luciani, GV Matthews, FMJ Lamoury, ... Infection, Genetics and Evolution 37, 252-258, 2016 | 6 | 2016 |
| Identification of critical residues in the bifunctional phosphoenolpyruvate synthetase kinase/phosphotransferase of Escherichia coli S Bartlett, J Seeliger, JN Burnell Current Topics in Biochemical Research 14, 77-83, 2012 | 3 | 2012 |
| Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia M Martinello, S Bartlett, G Dore, R Bopage, R Finlayson, D Baker, M Bloch, ... Journal of Hepatology 68, S312-S313, 2018 | 2 | 2018 |
| A latent class approach to identify multi‐risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015 SR Bartlett, TL Applegate, BP Jacka, M Martinello, FMJ Lamoury, M Danta, ... Journal of the International AIDS Society 22 (2), e25222, 2019 | 1 | 2019 |
| Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types FMJ Lamoury, S Bartlett, B Jacka, B Hajarizadeh, J Grebely, GV Matthews, ... The Journal of Molecular Diagnostics 17 (5), 583-589, 2015 | 1 | 2015 |
| The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of Direct Acting Antivirals SR Bartlett, A Yu, N Chapinal, C Rossi, Z Butt, S Wong, M Darvishian, ... Liver International, 2019 | | 2019 |
| Sustained Virologic Response from Interferon-based Hepatitis C regimes IS associated with Reduced risk of Extrahepatic Manifestations C Rossi, D Jeong, S Wong, G McKee, ZA Butt, J Buxton, J Wong, ... Journal of hepatology, 2019 | | 2019 |
| P386 Cancer risk among people with HIV, HBV and/or HCV infections M Darvishian, C Rossi, S Wong, A Yu, J Wong, J Buxton, M Gilbert, ... Sexually Transmitted Infections 95 (Suppl 1), A190-A191, 2019 | | 2019 |
| P388 Evolution of hepatitis C care cascades among HIV and hepatitis B co-infected patients in british columbia, canada G Mckee, N Chapinal, Z Butt, C Rossi, S Wong, M Gilbert, J Wong, ... Sexually Transmitted Infections 95 (Suppl 1), A191-A191, 2019 | | 2019 |
| Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia SH Hooshyar, M Martinello, J Yee, S Bartlett, P Read, D Baker, J Post, ... JOURNAL OF HEPATOLOGY 70, E734-E734, 2019 | | 2019 |
| The impact of SVR from direct acting antiviral and interferon-based treatments for HCV on hepatocellular carcinoma risk in a large population based cohort N Janjua, S Wong, C Rossi, M Darvishian, A Yu, ZA Butt, E Yoshida, ... JOURNAL OF HEPATOLOGY 70, E736-E736, 2019 | | 2019 |
| Factors associated with hepatitis C treatment uptake among people who inject drugs in a population based data linkage study S Bartlett, S Wong, A Yu, M Alvarez, T Buller-Taylor, ZA Butt, M Darvishian, ... JOURNAL OF HEPATOLOGY 70, E210-E211, 2019 | | 2019 |
| CANCER RISK AMONG PEOPLE WITH HIV, HBV AND/OR HCV INFECTIONS M Darvishian, R Carmen, S Wong, A Yu, R Woods, M Binka, Z Butt, ... Liver 137, 0.02, 2019 | | 2019 |
| Moving Towards HCV Elimination Among People Living with HIV in Australia: Analysis of the CEASE Prospective Cohort Study M Martinello, J Yee, SR Bartlett, P Read, D Baker, J Post, R Finlayson, ... | | 2018 |
| Molecular epidemiology of recently acquired hepatitis C virus infection in Australia S Bartlett The Kirby Institute, 2017 | | 2017 |
| Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance SR Bartlett, J Grebely, AA Eltahla, JD Reeves, A Howe, V Miller, RA Bull, ... Journal of Hepatology 66 (1), S323, 2017 | | 2017 |
Jason GrebelyAssociate Professor, The Kirby Institute, UNSW SydneyVerified email at kirby.unsw.edu.au